StockData

Cigna vs Centene

CI and CNC side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CI and CNC compare

Cigna is the larger company, worth 2.3 times as much as Centene ($78.8B against $33.8B).

Centene grew revenue faster over the last twelve months (13.9% versus 7.8% for Cigna).

Cigna pays a dividend yielding 2.1%; Centene does not pay one.

Cigna scores higher on the StockData Score (8 against 6 for Centene), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCICNC
Size and price
Market cap$78.8B$33.8B
Share price$298.23$68.45
Change, 1 year−0.30%83.3%
Change, 5 years39.3%−7.7%
Beta (5Y)0.330.50
Employees68K61K
StockData Score
Total score8 (better)6
Valuation score22
Growth score22
Performance score00
Health score22
Dividend score2 (better)0
Valuation
P/S0.3×0.2× (better)
P/B1.8×1.5× (better)
EV/EBITDA8.2×–
P/FCF–3.8×
FCF yield–26.5%
Growth
Revenue growth (TTM)7.8%13.9% (better)
Revenue growth, 5Y average11.4%11.9% (better)
Net income growth (TTM)–−348%
EPS growth (TTM)–−358%
EPS growth, 5Y average−0.69%–
Profitability
Gross margin20.6% (better)8.0%
Operating margin3.5% (better)−2.8%
Net margin–−2.5%
FCF margin–4.4%
Return on equity–−20.4%
Return on invested capital12.1% (better)−22.7%
Financial health
Debt / equity0.750.71 (better)
Net debt / EBITDA1.94–
Interest coverage7.2× (better)−8.6×
Current ratio0.851.15 (better)
Altman Z-score2.802.83 (better)
Piotroski F-score7 (better)4
Dividends and buybacks
Dividend yield2.1%–
Years of dividend growth5–
Dividend growth, 5Y average173%–
Buyback yield1.3% (better)−0.01%
Shareholder yield3.4% (better)−0.01%
Ownership
Held by institutions89.9%98.8%
Held by insiders0.41%0.79%
Insider net buying, 12 months−$65.8M−$14.6M (better)
Superinvestors holding4 (better)3
Short interest, % of float2.6%2.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.